Patient2Patient
Guided Patient Conversations
Company Overview
Snapshot
Founded in March 2023 by Assaf Tidhar and Amir Luzon, Patient2Patient operated with 1–10 employees. The company raised $165,000 across one funding round from Fusion VC. In April 2023, the company secured seed funding from Fusion VC.
Business overview
Patient2Patient is a digital healthcare company focused on patient engagement within the Health Tech & Life Sciences sector. The company leverages AI to connect individuals diagnosed with complex conditions, such as CHF, with peers who have successfully managed their diseases. This platform aims to improve patient outcomes, reduce costs, and promote health equity by providing personalized solutions with mentors and materials that foster a trusting and transparent environment throughout the patient journey. The company primarily serves the United States market.
Strategic signal
In March 2024, Patient2Patient ceased operations, indicating a significant shift in its business trajectory. This development suggests that the company faced challenges in its market or operational model, leading to its non-active status. For investors, this signals a need to understand the underlying factors that led to the cessation of operations, particularly given its recent seed funding and focus on AI-driven patient engagement.
Log in to access full profile ›Company Intelligence Q&A
- What is Patient2Patient's current operational status?
- Patient2Patient is currently non-active, having ceased operations in March 2024.
- When was Patient2Patient founded and by whom?
- Patient2Patient was founded in March 2023 by co-founders Assaf Tidhar and Amir Luzon.
- What was Patient2Patient's total disclosed funding?
- Patient2Patient raised a total of $165,000 in a seed round in April 2023 from Fusion VC.
- Which investor participated in Patient2Patient's funding round?
- Fusion VC participated in Patient2Patient's seed funding round, which closed in April 2023 with $165,000.
- What was a key strategic milestone for Patient2Patient in 2023?
- In July 2023, Patient2Patient was selected as one of 10 Israeli companies for Assuta's 'RISE With US' program.